SCREENING FOR COLORECTAL NEOPLASIA - PHYSICIANS ADHERENCE TO COMPLETE DIAGNOSTIC EVALUATION

被引:42
|
作者
MYERS, RE [1 ]
BALSHEM, AM [1 ]
WOLF, TA [1 ]
ROSS, EA [1 ]
MILLNER, L [1 ]
机构
[1] TEMPLE UNIV,DEPT SOCIAL ADM,PHILADELPHIA,PA 19122
关键词
D O I
10.2105/AJPH.83.11.1620
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This prospective study was done in a health maintenance organization colorectal cancer screening program to determine whether 166 persons found to have abnormal fecal occult blood test results typically underwent complete diagnostic evaluation (i.e., either colonoscopy or barium enema x-ray plus flexible sigmoidoscopy). Chart audit data show that 137 (82%) subjects contacted a physician to discuss follow-up. A complete diagnostic evaluation was recommended to only 52 (38%) patients who talked with a physician. Forty-two (81%) patients who were advised to get a complete diagnostic evaluation actually complied. Significant differences in clinical findings were observed for patients who did and did not have a complete diagnostic evaluation.
引用
收藏
页码:1620 / 1622
页数:3
相关论文
共 50 条
  • [1] ADHERENCE TO CONTINUOUS SCREENING FOR COLORECTAL NEOPLASIA
    MYERS, RE
    BALSHEM, AM
    WOLF, TA
    ROSS, EA
    MILLNER, L
    [J]. MEDICAL CARE, 1993, 31 (06) : 508 - 519
  • [2] Measuring complete diagnostic evaluation in colorectal cancer screening
    Myers, RE
    Fishbein, G
    Hyslop, T
    Hauck, WW
    Kutch, M
    Grana, JR
    Schlackman, N
    [J]. CANCER DETECTION AND PREVENTION, 2001, 25 (02): : 174 - 182
  • [3] Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening
    Myers, RE
    Hyslop, T
    Gerrity, M
    Schlackman, N
    Hanchak, N
    Grana, J
    Turner, BJ
    Weinberg, D
    Hauck, WW
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1999, 8 (07) : 587 - 593
  • [4] Complete diagnostic evaluation in colorectal cancer screening: Research design and baseline findings
    Myers, RE
    Turner, B
    Weinberg, D
    Hauck, WW
    Hyslop, T
    Brigham, T
    Rothermel, T
    Grana, J
    Schlackman, N
    [J]. PREVENTIVE MEDICINE, 2001, 33 (04) : 249 - 260
  • [5] Screening for colorectal neoplasia
    Kronborg, O
    [J]. ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (02): : 127 - 129
  • [6] SCREENING FOR COLORECTAL NEOPLASIA
    PYE, G
    HARDCASTLE, JD
    [J]. PRACTITIONER, 1987, 231 (1424) : 183 - &
  • [7] Screening for Colorectal Neoplasia
    Inadomi, John M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02): : 149 - 156
  • [8] Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia
    Limburg, PJ
    Devens, ME
    Harrington, JJ
    Diehl, NN
    Mahoney, DW
    Ahlquist, DA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (10): : 2299 - 2305
  • [9] Diagnostic yield of colorectal neoplasia in daily clinical practice: consequences for future colorectal cancer screening?
    Droste, J. S. Terhaar Sive
    Craanen, M. E.
    van der Hulst, R. W. M.
    Bartelsman, J. F.
    Bezemer, P. D.
    Cappendijk, K. R.
    Meijer, G. A.
    Morsink, L. M.
    Snel, P.
    Tuynman, H. A. R. E.
    van Wanrooy, R. L. J.
    Wesdorp, I. C. E.
    Mulder, C. J. J.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A37 - A38
  • [10] DIAGNOSIS AND SCREENING OF COLORECTAL NEOPLASIA
    MCGILL, DB
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 1992, 8 (01) : 25 - 30